Evidence map›Paper›PMID 28955612›Full record

Review3 Biotech2017

Endophytic bacteria: a new source of bioactive compounds.

Monika Singh, Ajay Kumar, Ritu Singh, Kapil Deo Pandey

Abstract readReview
In one paragraph

Review in 3 Biotech, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 1 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 1 synthesis or guideline pooled it, 353 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Complete genome sequence ofMicrobiology resource announcements · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Efficacy of Endophytic BacteriumJournal of microbiology and biotechnology · 2025
    Article
  14. Review
  15. Article
  16. Isolation and evaluation of growth-promoting endophytic bacteria fromPhysiology and molecular biology of plants : an international journal of functional plant biology · 2025
    Article
  17. Promising protective treatment potential of endophytic bacteriumJournal of Zhejiang University. Science. B · 2025
    Article
  18. Review
  19. Article
  20. Multi-Omics on Traditional Medicinal Plant of the GenusMolecules (Basel, Switzerland) · 2024
    Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Monika SinghCentre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, 221005 India.
Ajay KumarCentre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, 221005 India.
Ritu SinghCentre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, 221005 India.
Kapil Deo PandeyCentre of Advanced Study in Botany, Institute of Science, Banaras Hindu University, Varanasi, 221005 India.
Banaras Hindu University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, bioactive compounds are in high demand in the pharmaceuticals and naturopathy, due to their health benefits to human and plants. Microorganisms synthesize these compounds and some enzymes either alone or in association with plants. Microbes residing inside the plant tissues, known as endophytes, also produce an array of these compounds. Endophytic actinomycetes act as a promising resource of biotechnologically valuable bioactive compounds and secondary metabolites. Endophytic

Indexed as

Antimicrobial agentsBioactive compoundsEndophytic bacteriaModulationPhytohormonesSecondary metabolites

Identifiers

PMID28955612
PMCPMC5599378
OpenAlexW2754738014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.